Literature DB >> 16404749

Acute and long-term outcomes of the novel side access (SLK-View) stent for bifurcation coronary lesions: a multicenter nonrandomized feasibility study.

Fumiaki Ikeno1, Young-Hak Kim, Jorge Luna, Jose A Condado, Antonio Colombo, Eberhard Grube, Peter J Fitzgerald, Seung-Jung Park, Alan C Yeung.   

Abstract

OBJECTIVE: To evaluate technical feasibility and procedural safety of SLK-View stent for treating bifurcation lesions.
BACKGROUND: Percutaneous treatment of coronary bifurcation lesions represents a technical challenge. Several stenting techniques and dedicated devices have proven unsuccessful, with high rates of side branch occlusion at index procedure and follow-up.
METHODS: Eighty one patients with 84 de novo coronary artery lesions involving a major side branch underwent SLK-View (Advanced Stent Technologies, Inc., Pleasanton, CA) stent implantation with subsequent kissing balloon post dilatation. SLK-View stent is a new scaffolding device incorporating a side aperture that allows access to the side-branch of a bifurcation after deployment of the stent in main vessel. All patients underwent angiographic follow-up at 6 months. Procedural, in-hospital, and 6-month follow-up outcomes were examined.
RESULTS: The lesions were located in left main (n = 11), left anterior descending (n = 50), left circumflex (n = 8), right coronary artery (n = 7), and 1 ramus intermedius. The most frequent lesions (44.1%) were true bifurcations. Successful stent delivery to bifurcation was accomplished in 82/84 of the cases (97.6%). Technical success was obtained in 99 and 94% of main vessel and side branches, respectively. Stenting in side-branch was performed in 21 lesions (25%). Side-branches were accessed effectively in 100% of bifurcations postprocedurally. Binary restenosis rate at 6-month follow-up was 28.3% and 37.7% for main vessel and side-branch, respectively. TLR rate at 6-month follow-up was 21% and CABG rate of 6%.
CONCLUSION: In this consecutive multicenter series of patients with coronary bifurcation lesions, this novel side-branch access stent proved feasible, with a high procedural success rate, while maintaining side-branch access. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16404749     DOI: 10.1002/ccd.20556

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

Review 1.  Dedicated bifurcation stents.

Authors:  Ajith Ananthakrishna Pillai; Balachander Jayaraman
Journal:  Indian Heart J       Date:  2012-04-28

Review 2.  Dedicated bifurcation analysis: dedicated devices.

Authors:  Carlos Collet; Ricardo A Costa; Alexandre Abizaid
Journal:  Int J Cardiovasc Imaging       Date:  2011-03-17       Impact factor: 2.357

3.  Evaluation of local flow conditions in jailed side branch lesions using computational fluid dynamics.

Authors:  Sang-Hoon Na; Bon-Kwon Koo; Jeong Chul Kim; Han-Mo Yang; Kyung-Woo Park; Hyun-Jae Kang; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

Review 4.  Novel drug-eluting stents in the treatment of de novo coronary lesions.

Authors:  Davide Capodanno; Fabio Dipasqua; Corrado Tamburino
Journal:  Vasc Health Risk Manag       Date:  2011-02-25

5.  Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samples.

Authors:  Stefan Kralev; Benjamin Haag; Jens Spannenberger; Siegfried Lang; Marc A Brockmann; Soenke Bartling; Alexander Marx; Karl-Konstantin Haase; Martin Borggrefe; Tim Süselbeck
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.